	1.	Article Title: Clinical characteristics and prognosis analysis of acute symptomatic seizures secondary to autoimmune encephalitis
	•	Line(s): 1-2
	•	Section: Title
	•	Quote(s): “Clinical characteristics and prognosis analysis of acute symptomatic seizures secondary to autoimmune encephalitis”
	2.	Publication Year: 2024
	•	Line(s): 5
	•	Section: Journal Citation
	•	Quote(s): “Frontiers in Neurology, Published: 30 October 2024”
	3.	Region: Asia
	•	Line(s): 10-12
	•	Section: Author Affiliations
	•	Quote(s): “First Clinical Medical College, Ningxia Medical University, Yinchuan, China”
	4.	Country: China
	•	Line(s): 10-12
	•	Section: Author Affiliations
	•	Quote(s): “First Clinical Medical College, Ningxia Medical University, Yinchuan, China”
	5.	Study Coverage Area: Single hospital study (General Hospital of Ningxia Medical University, Yinchuan)
	•	Line(s): 30-32
	•	Section: Methods
	•	Quote(s): “Clinical data were collected from 84 patients diagnosed with AE at the General Hospital of Ningxia Medical University between January 2015 and January 2023.”
	6.	Study Design: Retrospective cohort study
	•	Line(s): 30-34
	•	Section: Methods
	•	Quote(s): “This study aimed to analyze the clinical characteristics and prognosis of patients with autoimmune encephalitis (PWAE) who experienced seizures during the acute phase.”
	7.	Population Cohort: Patients with autoimmune encephalitis (AE)
	•	Line(s): 30-34
	•	Section: Methods
	•	Quote(s): “Clinical data were collected from 84 patients diagnosed with AE.”
	8.	Population Characteristics: Median age 46 years, 58.33% male
	•	Line(s): 90-92
	•	Section: Results
	•	Quote(s): “The median age of the 84 PWAE was 46.00 (29.00 ~ 58.75) years, with males accounting for 58.33% (49/84) and females accounting for 41.67% (35/84).”
	9.	Data Source: Hospital medical records
	•	Line(s): 30-32
	•	Section: Methods
	•	Quote(s): “Clinical data were collected from 84 patients diagnosed with AE at the General Hospital of Ningxia Medical University.”
	10.	Prospective or Retrospective: Retrospective
	•	Line(s): 30
	•	Section: Methods
	•	Quote(s): “Clinical data were collected from 84 patients diagnosed with AE at the General Hospital of Ningxia Medical University between January 2015 and January 2023.”
	11.	Sites or Centers Involved: Single center (General Hospital of Ningxia Medical University)
	•	Line(s): 30-32
	•	Section: Methods
	•	Quote(s): “Clinical data were collected from 84 patients diagnosed with AE at the General Hospital of Ningxia Medical University.”
	12.	Study Duration: January 2015 – January 2023
	•	Line(s): 30-32
	•	Section: Methods
	•	Quote(s): “Clinical data were collected from 84 patients diagnosed with AE at the General Hospital of Ningxia Medical University between January 2015 and January 2023.”
	13.	Population Ethnicity: NR
	14.	Disease Analysis: Autoimmune encephalitis (AE) and seizure outcomes
	•	Line(s): 27-30
	•	Section: Methods
	•	Quote(s): “This study aimed to analyze the clinical characteristics and prognosis of patients with autoimmune encephalitis (PWAE) who experienced seizures during the acute phase.”
	15.	Classification or Diagnosis: Graus criteria (2016) and Chinese expert consensus (2022)
	•	Line(s): 82-86
	•	Section: Methods
	•	Quote(s): “The inclusion criteria refer to the diagnostic criteria proposed by Graus et al. (2016) and the expert consensus on the diagnosis and treatment of AE in China (2022 edition).”
	16.	Diagnosis Criteria Details: Graus criteria (2016) and Chinese expert consensus (2022)
	•	Line(s): 82-86
	•	Section: Methods
	•	Quote(s): “The inclusion criteria refer to the diagnostic criteria proposed by Graus et al. (2016) and the expert consensus on the diagnosis and treatment of AE in China (2022 edition).”
	17.	Disease Phase: Acute or subacute
	•	Line(s): 92-94
	•	Section: Results
	•	Quote(s): “Seizures are common in the early stages of AE, with faciobrachial dystonic seizures (FBDS) characteristic of anti-LGI1 encephalitis and SE and super-refractory status epilepticus (Sup-RSE) frequently observed in anti-NMDAR encephalitis.”
	18.	Cohort Age Group: Adult (median 46 years)
	•	Line(s): 90-92
	•	Section: Results
	•	Quote(s): “The median age of the 84 PWAE was 46.00 (29.00 ~ 58.75) years.”
	19.	Female Percentage in Cohort: 41.67%
	•	Line(s): 90-92
	•	Section: Results
	•	Quote(s): “The median age of the 84 PWAE was 46.00 (29.00 ~ 58.75) years, with males accounting for 58.33% (49/84) and females accounting for 41.67% (35/84).”
	20.	Patient Number of Autoimmune Encephalitis: 84 patients
	•	Line(s): 94
	•	Section: Results
	•	Quote(s): “A total of 84 patients were enrolled, with 76.19% (64/84) in the seizure group and 23.81% (20/84) in the non-seizure group.”
	•	Subtypes and Patient Numbers:
	•	Anti-NMDAR: 32 patients
	•	Anti-LGI1: 26 patients
	•	Anti-CASPR2: 7 patients
	•	Anti-GABABR: 6 patients
	•	Anti-GAD65: 5 patients
	•	Multiple anti-neuronal antibodies: 8 patients
	21.	Follow-up Period: 2 years
	•	Line(s): 213-215
	•	Section: Results
	•	Quote(s): “At 2-year follow-up, there was no significant difference in prognosis between the seizure and non-seizure groups (p = 0.653).”
	22.	Age of Patients by Subtype:
	•	Anti-NMDAR:
	•	Median: 27.5 years
	•	IQR: 18.75 – 32.25 years
	23.	Age of Diagnosis by Subtype: NR